Project Grant R21EY036605

Award Date 9/30/24
Completion Date 8/31/26
Dollars Obligated $242K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $2,636,322 to investigate an Artificial Intelligence (AI)-based system to improve eye screening and follow-up care rates for patients with diabetes, particularly in socioeconomically disadvantaged communities. The project, titled "Leveraging Artificial Intelligence to Prevent Vision Loss from Diabetes Among Socioeconomically Disadvantaged Communities," will...
The National Eye Institute (NEI) awarded a $718,397 Project Grant through the Vision Research federal grant program (CFDA 93.867) to Northwestern University to conduct the "Health Equity and Access to Leverage Technology for Improved Diabetic Retinopathy Outcomes (HEAL-DR)" study. This research aims to develop new predictive models using optical coherence tomography (OCT) data and social determinants of health to better identify minority populations at high risk for diabetic...
The National Eye Institute (NEI) awarded Vanderbilt University Medical Center a $2,305,702 Project Grant (CFDA 93.867 - Vision Research) to conduct an integrative multi-omics study to discover molecular pathways associated with diabetic retinopathy (DR). The 5-year project aims to: 1) quantify differential transcript and metabolite abundance between participants with type 2 diabetes with and without DR in the Cameron County Hispanic Cohort and replicate findings in the Hispanic Community...
The National Eye Institute (NEI) has awarded a $144,362 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The award, effective September 1, 2024 through February 28, 2027, will support research to investigate the role of hyperglycemia and hyperinsulinemia in the breakdown of the blood-retinal barrier, which is a leading cause of diabetic retinopathy and preventable blindness. The...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) supports research into diabetic retinal neurodegeneration in youth with type 1 and type 2 diabetes. The $155,000 award will be used by The Johns Hopkins University to determine if retinal nerve layer thinning is associated with duration of diabetes, glycemic control, and social determinants of health in youth with type 1 diabetes (Aim 1). The study will also compare...
This federal Project Grant award, valued at $469,854 and provided by the National Eye Institute (NEI), supports research to investigate the contribution of histone deacetylase 6 (HDAC6) and sirtuin-1 (SIRT-1) to retinal vascular senescence, diabetic retinal microangiopathy, and diabetic retinopathy (DR). The award, made under the NEI's Vision Research program (CFDA 93.867), aims to validate the working hypothesis that an imbalance between HDAC6 and SIRT-1 leads to exosome-mediated retinal...
This National Eye Institute (NEI) Project Grant award under the Vision Research program (CFDA 93.867) provides $215,454 to Duke University to develop a novel robotic optical coherence tomography (OCT) system capable of automatically measuring a retinal biomarker related to photoreceptor degeneration in diabetic retinopathy. The project aims to leverage the precise beam control capabilities of the robotic OCT system to visualize and quantify changes in the outer nuclear layer (ONL) of the retina,...
This $131,281 Project Grant was awarded by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867). The grant will support research at Northwestern University to investigate the role of myeloid cell transmigration in the progression of non-proliferative diabetic retinopathy (DR). The key objectives are to determine whether and when blocking myeloid cell infiltration can halt DR inflammation, and if blocking leukocyte-endothelial interactions early in the...
This $433,841 federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports the development of computational methods and deep learning models to analyze imaging data and identify biomarkers for age-related macular degeneration (AMD). The goal is to improve understanding of AMD disease progression and response to treatment. Specifically, the project will develop deep neural network models to analyze optical coherence tomography,...
The National Eye Institute (NEI) awarded Oakland University a 2-year, $184,117 Project Grant (CFDA 93.867 Vision Research) to investigate the role of G-Coupled Protein Receptors 31 and 39 (GPR31/GPR39) in the pathogenesis of diabetic retinopathy. The researchers will determine the affinities and specificities of GPR31 and GPR39 for the 12/15-lipoxygenase metabolites 12-HETE and 15-HETE, and examine the effects of GPR31/GPR39 gain-loss-of-function on retinal endothelial cells and Müller cells...

This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), will support research to evaluate the impact of patient, neighborhood, and community characteristics on screening and monitoring adherence for diabetic retinopathy among Medicare beneficiaries with diabetes.

The $241,500 award to Duke University, spanning September 2024 to August 2026, will utilize Medicare data linked with the Area Deprivation Index and local healthcare environment measures to identify factors associated with adherence to recommended screening and monitoring intervals for diabetic retinopathy. This research aims to inform quality measures, reimbursement incentives, and resource allocation to decrease the rising incidence of preventable blindness from diabetic retinopathy affecting over 10 million Americans.

Generated 6/10/25, 6:02 AM